Insider · CIK 0001975031
Christopher McCarthy
Files at IDXG (INTERPACE BIOSCIENCES, INC.). First filing -, latest -.
In brief
Christopher McCarthy files SEC Form 4 as CFO and COO at IDXG (INTERPACE BIOSCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher McCarthy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | IDXG INTERPACE BIOSCIENCES, INC. | MOption exercise Common Stock | +277,009 | $0.00 | $0 | 323,800 | Aug 20, 2026 |
| Aug 20, 2026 | IDXG INTERPACE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +554,018 | $0.00 | $0 | 554,018 | Aug 20, 2026 |
| Aug 20, 2026 | IDXG INTERPACE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -277,009 | $0.00 | $0 | 277,009 | Aug 20, 2026 |
| Aug 20, 2026 | IDXG INTERPACE BIOSCIENCES, INC. | AGrant or award Stock Option (right to buy)derivative | +277,009 | $0.00 | $0 | 277,009 | Aug 20, 2026 |
| Jul 31, 2023 | IDXG INTERPACE BIOSCIENCES, INC. | MOption exercise Common Stock | +7,556 | $0.00 | $0 | 15,872 | Apr 25, 2025 |
| Dec 1, 2023 | IDXG INTERPACE BIOSCIENCES, INC. | MOption exercise Common Stock | +1,095 | $0.00 | $0 | 16,967 | Apr 25, 2025 |
| Jan 31, 2024 | IDXG INTERPACE BIOSCIENCES, INC. | MOption exercise Common Stock | +7,556 | $0.00 | $0 | 24,523 | Apr 25, 2025 |
| Feb 1, 2024 | IDXG INTERPACE BIOSCIENCES, INC. | MOption exercise Common Stock | +6,045 | $0.00 | $0 | 30,568 | Apr 25, 2025 |
| Jul 27, 2024 | IDXG INTERPACE BIOSCIENCES, INC. | MOption exercise Common Stock | +15,112 | $0.00 | $0 | 45,680 | Apr 25, 2025 |
| Dec 1, 2024 | IDXG INTERPACE BIOSCIENCES, INC. | MOption exercise Common Stock | +1,111 | $0.00 | $0 | 46,791 | Apr 25, 2025 |
| Feb 1, 2024 | IDXG INTERPACE BIOSCIENCES, INC. | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 45,644 | Feb 6, 2024 |
Questions about Christopher McCarthy
Answered from the filings on this page, as of the latest one.
Is Christopher McCarthy buying or selling?
Christopher McCarthy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher McCarthy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher McCarthy has 0.
Where does Christopher McCarthy file Form 4?
Christopher McCarthy has filed Form 4 at IDXG (INTERPACE BIOSCIENCES, INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.